SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032757
Filing Date
2022-11-17
Accepted
2022-11-17 16:05:49
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1192841
2 ex10-1.htm EX-10.1 418319
3 ex10-2.htm EX-10.2 100881
4 ex10-3.htm EX-10.3 141556
5 ex31-1.htm EX-31.1 18562
6 ex31-2.htm EX-31.2 11749
7 ex32-1.htm EX-32.1 4942
8 ex32-2.htm EX-32.2 5035
  Complete submission text file 0001493152-22-032757.txt   7131858

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE rspi-20220930.xsd EX-101.SCH 55495
10 XBRL CALCULATION FILE rspi-20220930_cal.xml EX-101.CAL 40146
11 XBRL DEFINITION FILE rspi-20220930_def.xml EX-101.DEF 258536
12 XBRL LABEL FILE rspi-20220930_lab.xml EX-101.LAB 430584
13 XBRL PRESENTATION FILE rspi-20220930_pre.xml EX-101.PRE 320859
51 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1023876
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 221398377
SIC: 2834 Pharmaceutical Preparations